SciELO - Scientific Electronic Library Online

vol.21 número8Estudio descriptivo del comienzo de la diabetes mellitus tipo 1 y sus familiares de primer gradoColitis microscópica: Un diagnóstico a tener en cuenta en caso de diarrea secretora índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados




Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google


Anales de Medicina Interna

versión impresa ISSN 0212-7199


ALVAREZ-RODRIGUEZ, E. et al. Neurocysticercosis: report of three cases and recommendations of treatment. An. Med. Interna (Madrid) [online]. 2004, vol.21, n.8, pp.24-28. ISSN 0212-7199.

Neurocysticercosis is a pathology that we are finding nowadays over the immigrant population. It is produced by the Taenia solium parasite when it encyst into the central nervous system. The most frequent clinic is the focal crisis though it can come up as a general crisis; hydrocephalus, intracranial hypertension and even encephalitis can also happen. Its diagnosis is mainly based on imaging methods. The treatment is still controversial and must be individualized. The indication of antiparasitic drugs like albendazole and praziquantel has to be considered depending on the viability of the parasite, the number of cysts and their localization. If a cyst grows up the treatment is always recommended. In the case of an intracranial hypertension arises, this has to be treated before initiating any other action against the parasitic disease. Antiepileptic drugs are necessary to treat the symptoms. In some cases it is also recommended the use of steroids before and during the administration of antiparasitic therapy and even independently on their own.

Palabras clave : Cysticercosis; Neurocysticercosis; Cestode; Taenia solium; Epilepsy; Antiparasitic drugs; Albendazole; Praziquantel.

        · resumen en Español     · texto en Español     · Español ( pdf )


Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons